Chronic hepatitis B virus infection

Related records

Broader conditions (19)

• Digestive system disorder
• Digestive system infectious disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Endocrine system disorder
• Hepadnaviridae infectious disease
• Hepatitis
• Hepatitis B virus infection
• Hepatobiliary disorder
• Human disease
• Infectious disease
• Inflammatory disease
• Liver disorder
• Primary viral infectious disease
• Viral hepatitis
• Viral infectious disease

Trials (856)

• "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
• 3E Extension Study
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
• A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
• A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial
• A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB
• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
• A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection
• A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
• A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients
• A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
• A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
• A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
• A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B
• A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects
• A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB
• A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
• A Clinical Trials to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With HBV

Approved drugs (10)

• Adefovir dipivoxil
• Entecavir
• Hepatitis B immune globulin
• Hepatitis B virus hbsag surface protein antigen
• Interferon alfa-2B
• Lamivudine
• Peginterferon alfa-2A
• Telbivudine
• Tenofovir alafenamide fumarate
• Tenofovir disoproxil fumarate

Drugs in development (67)

• AB-101 Phase 1
• Adefovir Phase 3
• Albinterferon alfa-2B Phase 1
• Antroquinonol Phase 2
• APG-1387 Phase 2
• Bepirovirsen Phase 3
• Bersacapavir Phase 2
• Besifovir Phase 3
• Celecoxib Phase 2
• Cetrelimab Phase 1
• Chlorpheniramine Phase 2
• Clevudine Phase 3
• Daunorubicin Phase 3
• Diammonium glycyrrhizinate Phase 3
• Digoxin Phase 1
• Diphenhydramine Phase 2
• Durvalumab Phase 2
• Elebsiran Phase 2
• Elvucitabine Phase 2
• Emtricitabine Phase 3

Other linked drugs (3)

• Interferon
• Metformin
• Prednisone